Additional file 1 of Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study

Bayle, Arnaud; Belcaid, Laila; Palmieri, Lola-Jade; Teysonneau, Diego; Cousin, Sophie; Spalato-Ceruso, Mariella; Aldea, Mihaela; Vasseur, Damien; Alame, Melissa; Blouin, Laura; Soubeyran, Isabelle; Nicotra, Claudio; Ngocamus, Maud; Hollebecque, Antoine; Loriot, Yohann; Besse, Benjamin; Lacroix, Ludovic; Rouleau, Etienne; Barlesi, Fabrice; Andre, Fabrice; Italiano, Antoine

doi:10.6084/m9.figshare.24499380.v1

12943_2023_1878_MOESM1_ESM.docx (16.75 kB)

Additional file 1 of Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study

journal contribution

posted on 2023-11-04, 05:01 authored by Arnaud Bayle, Laila Belcaid, Lola-Jade Palmieri, Diego Teysonneau, Sophie Cousin, Mariella Spalato-Ceruso, Mihaela Aldea, Damien Vasseur, Melissa Alame, Laura Blouin, Isabelle Soubeyran, Claudio Nicotra, Maud Ngocamus, Antoine Hollebecque, Yohann Loriot, Benjamin Besse, Ludovic Lacroix, Etienne Rouleau, Fabrice Barlesi, Fabrice Andre, Antoine Italiano

Supplementary Material 1

Funding

Fondation Gustave Roussy FONDATION BERGONIE

History

Usage metrics

Keywords

ctDNA Targeted therapy Resistance biomarkers Next-generation sequencing

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1 of Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study

Funding

Fondation Gustave Roussy FONDATION BERGONIE

History

Usage metrics

Categories

Keywords

Licence

Exports